AlgoRx Pharmaceuticals Inc., of Secaucus, N.J., and Corgentech Inc., of South San Francisco, appointed Robert Zerbe as the ninth board member for the combined company...Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Richard Pascoe vice president and chief commercial officer

Unigen Pharmaceuticals Inc., of Lacey, Wash., appointed Regan Miles president and chief operating officer...ViroLogic Inc., of South San Francisco, appointed William Welch senior vice president and chief commercial officer

Human Genome Sciences Inc., of Rockville, Md., appointed Barry Labinger executive vice president and chief commercial officer...Intrac Inc., of New York, and its subsidiary Innovative Drug Delivery Systems, appointed William Peters to its board

Neurorecovery Inc., of Tuscaloosa, Ala., appointed Ben Labry and James Terwilliger to oversee business development and marketing activities...Replidyne Inc., of Louisville, Colo., appointed Peter Letendre chief commercial officer

ArQule Inc., of Woburn, Mass., appointed Dennis France and Shi-Chung Ng research leaders for the company's oncology portfolio...Myriad Genetics Inc., of Salt Lake City, named Mark Anderson vice president of chemistry, Robert Carlson vice president of discovery biology, Mark Laughlin chief medical officer and vice president of clinical research, and Wayne Laslie chief operating officer and chief commercial officer, all for Myriad Pharmaceuticals Inc

Corus Pharma Inc., of Seattle, appointed Dinu Sen chief commercial officer...Neurome Inc., of La Jolla, Calif., appointed Michael Khoury and Joseph Wender to its board

CoTherix Inc., of Belmont, Calif., appointed Thomas Feldman as chief commercial officer and Curtis Ruegg as senior vice president of technical operations...It also appointed Clark Springgate vice president of clinical and regulatory

Kalypsys Inc., of San Diego, added Stewart Noble as director of chemistry and Tadimeti Rao as director of pharmacology and preclinical development...Prestwick Pharmaceuticals Inc., of Washington, appointed David Cory chief commercial officer

Connetics Corp., of Palo Alto, Calif., named Michael Miller senior vice president and chief commercial officer...PhageTech Inc., of Montreal, elected Francois Legault and Rene Kurth to its board

Antigenics Inc., of New York, added Margaret Eisen, Wadih Jordan and Mark Kessel to its board and named Jeff Clark chief financial officer...Argenta Discovery Ltd., of Harlow, UK, appointed David Gees chief commercial officer

Prometheus Laboratories Inc., of San Diego, appointed Roger Hawley chief commercial officer and Holly Green chief people and communications officer

Affymetrix Inc., of Santa Clara, Calif., appointed Trevor Nicholls chief commercial officer, global operations...CytRx Corp., of Los Angeles, elected Louis Ignarro and Joseph Rubinfeld to its board...added Gerhard Weidner as director of research and development of its subsidiary, Protedyne GmbH, of Martinsried, Germany

Orphan Medical Inc., of Minneapolis, added Mark Perrin as executive vice president, chief commercial officer...Sagres Discovery Inc. , of Davis, Calif., added Neal Copeland and Tony Hunter to its scientific advisory board...Telik Inc., of South San Francisco, elected Edward Cantrall and Steven Goldring to its board

Diversys Ltd., of Cambridge, UK, added Pamela Hay as chief commercial officer...MPM Capital, of Cambridge, Mass., added Carl Weissman as venture partner and Kazumi Shiosaki as entrepreneur in residence

Biogen Inc., of Cambridge, Mass., appointed Burt Adelman executive vice president, research and development...Devgen NV, of Ghent, Belgium, added Lynn Butler as chief commercial officer

ArQule Inc., of Woburn, Mass., appointed Alan Hillyard chief information officer and Jean Devine director of investor relations...Aviron Inc., of Mountain View, Calif., appointed Ed Arcuri senior vice president and chief operating officer and Carol Olson senior vice president and chief commercial officer

Discovery Therapeutics Inc., of Richmond, Va., appointed William Wheeler vice president and chief medical officer and Kenneth Rice vice president and chief commercial officer...Human Genome Sciences Inc., of Rockville, Md., appointed Richard Holbrooke and Richard Danzig to its board

Connetics Corp., of Palo Alto, Calif., appointed Gregory Vontz executive vice president and chief commercial officer...and Indrajit Sanyal to director, high-throughput biological screening

Roche Molecular Systems Inc., of Pleasanton, Calif., named Martin Madaus, Joanne Spadoro and David Thomas as vice presidents...Trega Biosciences Inc., of San Diego, appointed Mark Schwartz vice president of commercial operations and chief commercial officer